Evaluation of I-131-Pentamidine for scintigraphy of experimentally Leishmania tropica-infected hamsters
dc.contributor.author | Inceboz, Tonay | |
dc.contributor.author | Lambrecht, Fatma Yurt | |
dc.contributor.author | Eren, Mine Sencan | |
dc.contributor.author | Girginkardesler, Nogay | |
dc.contributor.author | Bekis, Recep | |
dc.contributor.author | Yilmaz, Osman | |
dc.contributor.author | Er, Ozge | |
dc.contributor.author | Ozbilgin, Ahmet | |
dc.date.accessioned | 2019-10-27T22:14:45Z | |
dc.date.available | 2019-10-27T22:14:45Z | |
dc.date.issued | 2014 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | We aimed to assess the ability of I-131-Pentamidine scintigraphy to detect the lesions of Leishmania tropica infection. An experimental model of cutaneous leishmaniasis was developed. The presence of cutaneous leishmaniasis was confirmed. Pentamidine was radioiodinated with I-131. The radiolabeled pentamidine was validated by the requisite quality control tests to check its radiolabeling efficiency, in vitro stability. I-131-Pentamidine (activity: 18.5 MBq/100 mu l) was injected intracardiacally into infected hamsters. Static whole body images of the hamsters were acquired under the gamma camera at 5 and 30 min, 2, 6 and 24 h following the administration. On the scintigrams, anatomically adjusted regions of interest (ROIs) were drawn over the right feet (target) and left feet (not-target) and various organs. Accumulation of I-131-Pentamidine at sites of infection is expressed as the target to non-target (T/NT) ratio. The results T/NT ratio decreased with time. In concluding the I-131-Pentamidine has poor sensitivity in detection of L. tropica infection. | en_US |
dc.identifier.doi | 10.3109/1061186X.2013.878943 | en_US |
dc.identifier.endpage | 420 | en_US |
dc.identifier.issn | 1061-186X | |
dc.identifier.issn | 1029-2330 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 24405123 | en_US |
dc.identifier.startpage | 416 | en_US |
dc.identifier.uri | https://doi.org/10.3109/1061186X.2013.878943 | |
dc.identifier.uri | https://hdl.handle.net/11454/50064 | |
dc.identifier.volume | 22 | en_US |
dc.identifier.wos | WOS:000336500400006 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Informa Healthcare | en_US |
dc.relation.ispartof | Journal of Drug Targeting | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Amastigote | en_US |
dc.subject | I-131-Pentamidine scintigraphy | en_US |
dc.subject | Leishmania tropica | en_US |
dc.subject | Leishmaniasis hamster | en_US |
dc.subject | promastigote | en_US |
dc.title | Evaluation of I-131-Pentamidine for scintigraphy of experimentally Leishmania tropica-infected hamsters | en_US |
dc.type | Article | en_US |